INSM Q4 2024 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$104M+24.8% YoY

Gross Profit

$78M75.0% margin

Operating Income

-$230M-220.6% margin

Net Income

-$236M-225.5% margin

EPS (Diluted)

$-1.32

QoQ Revenue Growth

+11.8%

Cash Flow

Operating Cash Flow

-$196M

Free Cash Flow

-$203M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$1.7B

Stockholders' Equity

$285M

Cash & Equivalents

$555M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$104M	$84M	+24.8%
Gross Profit	$78M	$65M	+20.0%
Operating Income	-$230M	-$178M	-29.2%
Net Income	-$236M	-$186M	-26.6%

Geographic Segments

UNITED STATES

$132M68%

JAPAN

$52M27%

Europe And The Rest Of The World

$11M6%